Artificial Intelligence (AI) in Cancer

Artificial Intelligence (AI) in Cancer

Report Scope:

The report highlights AI technology's current and future market potential for cancer applications. It provides a detailed analysis of the market drivers, restraints and opportunities. The report also covers market projections through 2029 and presents a competitive environment and product analysis. The report provides market estimates and forecasts based on application, cancer type and region. By application type, the market is segmented into cancer screening, diagnosis, therapy, drug discovery and development and others. By cancer type, the market is segmented into breast, lung, prostate, gastrointestinal, brain and others. By end user, the market is segmented into hospitals, diagnostic centers, pharmaceutical companies and research institutions. The report includes profiles of the key companies with detailed information about their business segments, financials, product portfolios and recent developments.

By geographical region, the market is segregated into North America, Europe, Asia Pacific and the Rest of the world. The North American region includes countries the U.S., Canada and Mexico. Europe includes Germany, the U.K., Italy, France, Spain and the Rest of Europe; Asia-Pacific includes China, Japan, India, South Korea, Australia and the Rest of Asia-Pacific. For market estimates, data is provided for 2021 and 2022 as the historic years, 2023 as the base year and 2029 as the forecast year.

Report Includes:

42 data tables and 44 additional tables

An up-to-date overview of the global markets for artificial intelligence (AI) in cancer

Analysis of the global market trends, with data from 2021-2023, estimates for 2024, and projections of compound annual growth rates (CAGRs) through 2029

Evaluation of the size of the market for artificial intelligence (AI) in cancer and revenue growth prospects, accompanied by a market share analysis by type, application, end user and region

Assessment of market dynamics such as drivers, restraints and opportunities

Coverage of current and emerging applications of AI in cancer and information on theranostics and generative AI tools

A discussion on ESG challenges and practices in the industry

Assessment of the vendor landscape, including the market shares of key companies, their product portfolios and financial overviews

Information on recent mergers, acquisitions, expansions, collaborations, investments, divestments, product launches, and other strategic developments

Company profiles of major players within the industry, including Siemens Healthineers, GE Healthcare, NVIDIA Corp., and Lunit Inc.

Companies Mentioned

Azra Ai
Concertai
Ge Healthcare
Icad Inc.
Lunit Inc.
Median Technologies
Nvidia Corp.
Quest Diagnostics Inc.
Siemens Healthineers Ag